Pulmotect's Series B Round

Pulmotect raised a round of funding on March 07, 2018.

Pulmotect is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.…

Articles about Pulmotect's Series B Round: